Last month, the Food and Drug Administration (FDA) approved Voquenza Dual (vonoprazan fumarate + amoxicillin) and Triple Paks (vonoprazan fumarate + amoxicillin + clarithromycin) for the treatment of ...

H. pylori bacteria can disrupt your stomach's protective lining and cause peptic ulcers. You can treat H. pylori infections with antibiotics and medications that lower acid to prevent complications. H ...

Globally, stomach cancer is on the rise in young people, but new research shows that three-quarters of future cases could be prevented by screening for and treating a common bacterial infection: ...

In addition to their associations with gastric disease, Helicobacter pylori infections have been related to reduced cognitive functions in previous studies, including the United States Centres for ...

European Stop Tyrosine Kinase Inhibitor Trial (EURO-SKI) in Chronic Myeloid Leukemia: Final Analysis and Novel Prognostic Factors for Treatment-Free Remission We conducted a retrospective cohort ...

Helicobacter pylori (H. pylori) is a common type of bacteria that infects the stomach lining and can lead to various gastrointestinal diseases such as gastritis, stomach ulcers, and cancer. The ...

H. pylori is a bacteria that can damage the stomach’s protective lining. Untreated, an H.pylori infection may lead to complications. H. pylori is a common type of bacteria that grows in the digestive ...

Helicobacter pylori is a Gram-negative, spiral-shaped, flagellated bacterium, that colonizes the gastric mucosa. Although the gastric mucosa is protected against bacterial infections, H. pylori adapts ...

While gastritis and gastric ulcer disease used to be put down to stress and dietary factors, it was discovered in the 1980s that the actual culprit is infection with a bacterium, H. pylori. This ...

The global helicobacter pylori infections treatment market is set for significant expansion, with a market value projected to reach USD 638.3 million in 2023. This robust growth trajectory is expected ...